☆ 4.6 Article

Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy

CANCERS (2022)

Related references

Note: Only part of the references are listed.

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

The Global Reading Room: Recovery of Breast Cancer Screening Services After the COVID-19 Pandemic First Wave

Evelyn Lai Ming Ho et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2022)

Add to Collection

Article Oncology

Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system

Annie Tang et al.

Summary: During the initial COVID-19 Shelter-in-Place period, fewer breast cancers were diagnosed at Kaiser Permanente Northern California, with a higher proportion of patients presenting with symptomatic disease. Early-stage breast cancer diagnoses decreased, while metastatic cancer diagnoses remained stable. Telehealth utilization significantly increased, and treatment times were shorter in 2020 compared to 2019.

BREAST CANCER RESEARCH AND TREATMENT (2022)

Add to Collection

Article Pathology

Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic Assessment of the Magnitude of the Problem and Proposals for Corrective Actions

Gerardo Ferrara et al.

Summary: The COVID-19 pandemic in 2020 led to a 44.9% decrease in cancer diagnoses, with skin cancers being the most affected. Decreases in diagnoses were most significant for colorectal, prostate, and bladder cancers, with high-grade prostate tumors showing a moderate impact.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Letter Pathology

Lockdown Measures Negatively Impacted Cancer Care

Sarita Kumari et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Article Oncology

The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020

Toral Gathani et al.

Summary: Delays in cancer diagnosis and treatment due to the COVID-19 pandemic are a widespread concern, with the impact varying across different tumor sites. Analysis of NHS data showed a decrease in referrals and treatments for suspected breast cancer in the first half of 2020 compared to 2019, but the actual number of breast cancers diagnosed was not as low as feared. Further research is needed to examine the specific impact of COVID-19 management measures on breast cancer outcomes.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures

Sarah J. Nyante et al.

Summary: Pandemic-related decreases in breast examinations gradually improved over time, with fewer exams than expected initially. Women receiving breast care during the pandemic had higher predicted breast cancer risk and were more likely to lack insurance compared to before the pandemic. Further long-term studies are needed to understand the impact of these trends on breast cancer disparities.

CANCER (2021)

Add to Collection

Letter Medicine, General & Internal

Decline in cancer pathology notifications during the 2020 COVID-19-related restrictions in Victoria

Luc te Marvelde et al.

MEDICAL JOURNAL OF AUSTRALIA (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

Anouk H. Eijkelboom et al.

Summary: The study examined the impact of the COVID-19 pandemic on the Dutch national breast screening program, with the suspension and restart of the program leading to a 67% decrease in the incidence of screen-detected breast tumors.

PREVENTIVE MEDICINE (2021)

Add to Collection

Article Oncology

Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic

Gianluca Vanni et al.

Summary: The COVID-19 lockdown measures had a significant impact on breast cancer patients, leading to increased tumor dimensions, advanced N-staging, and increased need for adjuvant treatments.

ANTICANCER RESEARCH (2021)

Add to Collection

Article Oncology

Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study

Anouk H. Eijkelboom et al.

Summary: The onset of the COVID-19 pandemic led to a decline in breast cancer incidence in early 2020, prompting rapid adaptations in treatment approaches. Factors such as tumor behavior, treatment modalities, and timing showed significant impact on breast cancer diagnosis and treatment, highlighting the need for further understanding on the effects of treatment delays on patient outcomes.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Add to Collection

Article Oncology

COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study

Eduard Vrdoljak et al.

Summary: The initial COVID-19 lockdown measures in Croatia led to a 24% reduction in newly diagnosed breast cancer cases during April, May, and June compared with the same period in 2019. However, by the end of 2020, the oncology health care system had shown resilience and compensated for the effects of the pandemic control measures.

ONCOLOGIST (2021)

Add to Collection

Article Oncology

Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era

A. Toss et al.

Summary: The study found that a 2-month interruption in breast cancer screening led to an increase in node-positive and stage III breast cancer patients, particularly among those with high proliferation rates. Despite the screening interruption, procedures to establish a definitive diagnosis and treatment start were not delayed.

ESMO OPEN (2021)

Add to Collection

Article Oncology

Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study

Ashleigh C. Hamilton et al.

Summary: The restructuring of healthcare systems during the COVID-19 pandemic has led to a significant decrease in cancer diagnoses, particularly for lung, prostate, and gynaecological malignancies. There is a critical need to protect cancer diagnostic services to facilitate timely investigation of potential cancer cases, and targeted public health campaigns may help reduce emerging inequalities in cancer diagnoses.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Delay in breast cancer diagnosis and its clinical consequences during the coronavirus disease pandemic

Bulent Koca et al.

Summary: After 1 year of the COVID-19 pandemic, breast cancer patients showed larger tumors, increased axillary lymph node involvement, and higher rates of neoadjuvant chemotherapy. Furthermore, there was a decrease in breast-conserving surgeries and an increase in mastectomies during the pandemic. Patients may face an increased risk of distant organ metastases in the future.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Delayed Breast Cancer Detection in an Asian Country (Taiwan) with Low COVID-19 Incidence

Chen-Pin Chou et al.

Summary: Despite the low incidence of COVID-19, Taiwan experienced a significant delay in early breast cancer detection during the pandemic. The number of breast biopsies, cases of early breast cancer, and invasive breast cancer all decreased during the COVID-19 period.

CANCER MANAGEMENT AND RESEARCH (2021)

Add to Collection

Article Oncology

Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France

J. Y. Blay et al.

Summary: The study found that the COVID-19 pandemic had a significant impact on cancer patient management at Unicancer comprehensive cancer centers in France, particularly for newly diagnosed patients, affecting more women, breast cancer, prostate cancer, and nonmetastatic cancer patients. Delays in treatment may lead to an increased risk of cancer-related deaths in the coming years.

ESMO OPEN (2021)

Add to Collection

Article Oncology

Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis

H. M. Peacock et al.

Summary: The study revealed a significant reduction in the number of invasive cancer diagnoses nationwide in 2020 due to the COVID-19 pandemic. The largest decrease was observed in older patients and those with skin cancers. However, the decline was less pronounced among children and adolescents.

ESMO OPEN (2021)

Add to Collection

Article Gastroenterology & Hepatology

Data from a large Western centre exploring the impact of COVID-19 pandemic on endoscopy services and cancer diagnosis

Gaius Longcroft-Wheaton et al.

Summary: The study investigated the impact of the COVID-19 pandemic on endoscopy services and gastrointestinal cancer diagnosis in a major hospital in the UK. Results showed a significant reduction in endoscopy procedures and GI cancer diagnoses during the crisis period. Changes in triage and management strategies led to a decrease in the number of procedures required for cancer diagnosis. The data can aid in healthcare planning for managing the increased workload on endoscopy departments during the recovery phase from COVID-19.

FRONTLINE GASTROENTEROLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Oncology

Epidemiology and biological characteristics of male breast cancer in Italy

Lucia Mangone et al.

BREAST CANCER (2020)

Add to Collection

Editorial Material Oncology

Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium

Jill R. Dietz et al.

BREAST CANCER RESEARCH AND TREATMENT (2020)

Add to Collection

Article Oncology

Breast Cancer Diagnosis in Coronavirus-Era: Alert From Italy

Gianluca Vanni et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Oncology

Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!

Claudia Omarini et al.

EUROPEAN JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic

Giuseppe Curigliano et al.

BREAST (2020)

Add to Collection

Letter Oncology

Call for ensuring cancer care continuity during COVID-19 pandemic

Marco Tagliamento et al.

ESMO OPEN (2020)

Add to Collection

Letter Oncology

The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands

Avinash G. Dinmohamed et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Add to Collection

Article Oncology

Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters

Jack W. London et al.

JCO CLINICAL CANCER INFORMATICS (2020)

Add to Collection

Article Oncology

Neoadjuvant therapy for breast cancer

Lucia Mangone et al.

TUMORI JOURNAL (2019)

Add to Collection

Article Oncology

Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?

Linda de Munck et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey

S. Deandrea et al.

PREVENTIVE MEDICINE (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.